Minocycline reduces prostaglandin E synthase expression and 8-isoprostane formation in LPS-activated primary rat microglia

References

• Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P.H., Koistinaho, J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 13496–13500.
   PubMed Web of Science ®Google Scholar
• Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., Koistinaho, J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 15769–15774.
   PubMed Web of Science ®Google Scholar
• Seabrook, T.J., Jiang, L., Maier, M., Lemere, C.A. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 2006, 53, 776–782.
   PubMed Web of Science ®Google Scholar
• Chen, M., Ona, V.O., Li, M., Ferrante, R.J., Fink, K.B., Zhu, S., Bian, J., Guo, L., Farrell, L.A., Hersch, S.M., Hobbs, W., Vonsattel, J.P., Cha, J.H., Friedlander, R.M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 2000, 6, 797–801.
   PubMed Web of Science ®Google Scholar
• Du, Y., Ma, Z., Lin, S., Dodel, R.C., Gao, F., Bales, K.R., Triarhou, L.C., Chernet, E., Perry, K.W., Nelson, D.L., Luecke, S., Phebus, L.A., Bymaster, F.P., Paul, S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 14669–14674.
   PubMed Web of Science ®Google Scholar
• Zhu, S., Stavrovskaya, I.G., Drozda, M., Kim, B.Y., Ona, V., Li, M., Sarang, S., Liu, A.S., Hartley, D.M., Wu, D.C., Gullans, S., Ferrante, R.J., Przedborski, S., Kristal, B.S., Friedlander, R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417, 74–78.
   PubMed Web of Science ®Google Scholar
• Bastos, L.F., Merlo, L.A., Rocha, L.T., Coelho, M.M. Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. Eur. J. Pharmacol. 2007, 576, 171–179.
   PubMed Web of Science ®Google Scholar
• Ledeboer, A., Sloane, E.M., Milligan, E.D., Frank, M.G., Mahony, J.H., Maier, S.F., Watkins, L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115, 71–83.
   PubMed Web of Science ®Google Scholar
• Tikka, T., Fiebich, B.L., Goldsteins, G., Keinanen, R., Koistinaho, J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 2001, 21, 2580–2588.
   PubMed Web of Science ®Google Scholar
• Milligan, E.D., Watkins, L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 2009, 10, 23–36.
   PubMed Web of Science ®Google Scholar
• Block, M.L., Hong, J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 2005, 76, 77–98.
   PubMed Web of Science ®Google Scholar
• Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., Kudo, I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 2000, 275, 32775–32782.
   PubMed Web of Science ®Google Scholar
• Jakobsson, P.J., Thorén, S., Morgenstern, R., Samuelsson, B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 7220–7225.
   PubMed Web of Science ®Google Scholar
• Tanikawa, N., Ohmiya, Y., Ohkubo, H., Hashimoto, K., Kangawa, K., Kojima, M., Ito, S., Watanabe, K. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem. Biophys. Res. Commun. 2002, 291, 884–889.
   PubMed Web of Science ®Google Scholar
• Watanabe, K., Kurihara, K., Suzuki, T. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim. Biophys. Acta 1999, 1439, 406–414.
   PubMed Web of Science ®Google Scholar
• de Oliveira, A.C., Candelario-Jalil, E., Bhatia, H.S., Lieb, K., Hüll, M., Fiebich, B.L. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia 2008, 56, 844–855.
   PubMed Web of Science ®Google Scholar
• Lovgren, A.K., Kovarova, M., Koller, B.H. cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis. Mol. Cell. Biol. 2007, 27, 4416–4430.
   PubMed Web of Science ®Google Scholar
• Jania, L.A., Chandrasekharan, S., Backlund, M.G., Foley, N.A., Snouwaert, J., Wang, I.M., Clark, P., Audoly, L.P., Koller, B.H. Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat. 2009, 88, 73–81.
   PubMed Web of Science ®Google Scholar
• Ikeda-Matsuo, Y., Ota, A., Fukada, T., Uematsu, S., Akira, S., Sasaki, Y. Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 11790–11795.
   PubMed Web of Science ®Google Scholar
• Boulet, L., Ouellet, M., Bateman, K.P., Ethier, D., Percival, M.D., Riendeau, D., Mancini, J.A., Méthot, N. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J. Biol. Chem. 2004, 279, 23229–23237.
   PubMed Web of Science ®Google Scholar
• Trebino, C.E., Stock, J.L., Gibbons, C.P., Naiman, B.M., Wachtmann, T.S., Umland, J.P., Pandher, K., Lapointe, J.M., Saha, S., Roach, M.L., Carter, D., Thomas, N.A., Durtschi, B.A., McNeish, J.D., Hambor, J.E., Jakobsson, P.J., Carty, T.J., Perez, J.R., Audoly, L.P. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 9044–9049.
   PubMed Web of Science ®Google Scholar
• Uematsu, S., Matsumoto, M., Takeda, K., Akira, S. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 2002, 168, 5811–5816.
   PubMed Web of Science ®Google Scholar
• Greco, A., Minghetti, L., Levi, G. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochem. Res. 2000, 25, 1357–1364.
   PubMed Web of Science ®Google Scholar
• Praticò, D., Barry, O.P., Lawson, J.A., Adiyaman, M., Hwang, S.W., Khanapure, S.P., Iuliano, L., Rokach, J., FitzGerald, G.A. IPF2alpha-I: an index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 3449–3454.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F., Roberts, L.J.2nd, . A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 9383–9387.
   PubMed Web of Science ®Google Scholar
• Candelario-Jalil, E., Akundi, R.S., Bhatia, H.S., Lieb, K., Appel, K., Muñoz, E., Hüll, M., Fiebich, B.L. Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production. J. Neuroimmunol. 2006, 174, 39–51.
   PubMed Web of Science ®Google Scholar
• Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• Kim, S.S., Kong, P.J., Kim, B.S., Sheen, D.H., Nam, S.Y., Chun, W. Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells. Arch. Pharm. Res. 2004, 27, 314–318.
   PubMed Web of Science ®Google Scholar
• Ryu, J.K., Franciosi, S., Sattayaprasert, P., Kim, S.U., McLarnon, J.G. Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 2004, 48, 85–90.
   PubMed Web of Science ®Google Scholar
• Fitzgerald, G.A. Coxibs and cardiovascular disease. N. Engl. J. Med. 2004, 351, 1709–1711.
   PubMed Web of Science ®Google Scholar
• Mehrotra, S., Morimiya, A., Agarwal, B., Konger, R., Badve, S. Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy. J. Pathol. 2006, 208, 356–363.
   PubMed Web of Science ®Google Scholar
• Alano, C.C., Kauppinen, T.M., Valls, A.V., Swanson, R.A. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 9685–9690.
   PubMed Web of Science ®Google Scholar
• Mishra, M.K., Ghosh, D., Duseja, R., Basu, A. Antioxidant potential of minocycline in Japanese encephalitis virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem. Int. 2009, 54, 464–470.
   PubMed Web of Science ®Google Scholar
• Bastos L.F., Angusti A., Vilaça M.C., Merlo L.A., Nascimento E.B., Jr, Rocha L.T., Godin A.M., Solano A.G., Jarussophon S., Nunan E.A., Konishi Y., Coelho M.M. A novel non-antibacterial, non-chelating hydroxypyrazoline derivative of minocycline inhibits nociception and oedema in mice. Br. J. Pharmacol. 2008, 155, 714–721.
   PubMed Web of Science ®Google Scholar
• Lertvorachon, J., Kim, J.P., Soldatov, D.V., Boyd, J., Roman, G., Cho, S.J., Popek, T., Jung, Y.S., Lau, P.C., Konishi, Y. 1,12-Substituted tetracyclines as antioxidant agents. Bioorg. Med. Chem. 2005, 13, 4627–4637.
   PubMed Web of Science ®Google Scholar
• Saliba, R., Paasch, L., El Solh, A. Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol. Immunotoxicol. 2009, 31, 583–588.
   PubMed Web of Science ®Google Scholar